Page 29 - 2022 DMOH Year-End Review Summary

DMOH Staff Win ASCO Awards

The 2022 ASCO Annual Meeting Program offered presentations on the latest research in cancer care. The
program featured sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through
Innovation. Please click here for a DMOH summary.
• Congratulations to our DMOH trainees who received a 2022 Conquer Cancer Merit Award: Drs. Lucy
Ma, Abhenil Mittal, Jesus Fuentes Antras, Sofia Genta, Alberto Hernando, Azeez Salawu, Enrique
Sanz, Pavlina Spiliopoulou, Kirsty Taylor, and Ana Veneziani.

• Congratulations to Dr. Azeez Salaw for receiving the Young Investigator Award for his project titled,
“Circulating Tumour DNA (ctDNA) Detection as a Potential Biomarker of Molecular Residual Disease in
Localized Soft Tissue Sarcoma (DNA-TSAR)”. His mentors were Drs. Albi Razak and David Shultz.

• Congratulations to Dr. Sofia Genta for receiving the Young Investigator Award for her project titled,
“Immune Resistance Interrogation Study (IRIS): Prospective Analysis of T-cell Function and Diversity
at the Time of Primary and Acquired Resistance to Cancer Immunotherapy”. Her mentors were Drs.
Anna Spreafico and Trevor Pugh.

th
The 64 ASH Annual Meeting and Exposition took place in New Orleans, Louisiana December 10-13, 2022.
Congratulations to DMOH staff for receiving an award, and to staff and learners for showcasing poster
presentations and abstracts. Please click here for a DMOH summary.

Congratulations to Dr. Dennis Kim for winning the ASH Achievement Award for the abstract Somatic Mutations
in Myeloid Transcription Factors and in Activated Signaling Pathway, but Not in Epigenetic Modifier Pathway,
Predict the Risk of Treatment Failure and Progression to Advanced Phase in Chronic Myeloid Leukemia.

2022 Year in Review Summary  29